MSACL 2025 15th Annual Conference & Exhibits

MSACL 2025 15th Annual Conference & Exhibits

👉REGISTER FOR THE EVENT

Mission

MSACL's mission is to support the community in overcoming the challenges of implementing high value tests in the clinical lab.

Conference Focus

MSACL is focused on providing a forum of interaction for participants in all stages of the development, advancement and use of analytical tools, including data analytics, in the clinic to improve patient care. Although the group primarily focuses on mass spectrometry, presentations and discussion on other platforms are welcome.

Deadlines

• Jun 18, 2025: EarlyBird Registration Ends
  • (1) Registration Deadline for PODIUM Presenters.
  • (2) If you intend to submit an abstract you should register now. If your abstract is not accepted your registration will be refunded at 100%.
• Jun 19, 2025: NO REGISTRATION REFUND after this date if registrant has an abstract accepted.
• Jul 17, 2025: FINAL POSTER Abstract Deadline
• Jul 23, 2025: Regular Registration Ends
  • (1) Registration Deadline for POSTER Presenters.
  • (2) Online registration remains open at Late Rates.
• Aug 15, 2025: Last Day for 90% Registration Refund, only if no abstract accepted
• Aug 26, 2025: GROUP HOTEL
  • Deadline to Cancel Group Rate Bonaventure reservations without Penalty*.
  • If the block has been sold-out to this point, and you were hoping to get a room within the Group Block, you will have until March 7 to secure a room from those that are cancelled by this date.
  • *On August 27, all Group reservations will be charged for the full booked stay without option for refund. If you're curious about why we need to do this, see description^ below.
• Aug 29, 2025: Last Day for 50% Registration Refund, ONLY if no abstract accepted.
  • NO REGISTRATION REFUND after this date.
• Sep 02, 2025: GROUP HOTEL
  • Hotel Bonaventure Cut-Off Date for Group Rate.
  • Last day to book a room at the Group Rate at the Bonaventure, if available.
• Sep 07, 2025: Last Day to Register for a Short Course.
• Sep 07, 2025: Late Registration Ends. Uber-Late pricing in effect. (1) Online registration remains open at Uber-Late Rates.

Registration fees

Conference Pass (Tue - Fri)

See rates below. Full access, except Short Courses are not included.

EarlyBird (by Jun 18, 2025)

• Industry / Commercial: USD$1580    
• Acad / Govt / Non-Profit: USD$870    
• Student / Post-Doc / Fellow: USD$430   
• Accompanying Individual: USD$405

Regular (after Jun 18, 2025)

• Industry / Commercial: USD$1680    
• Acad / Govt / Non-Profit: USD$920    
• Student / Post-Doc / Fellow: USD$450   
• Accompanying Individual: USD$430

Late (after Jul 23, 2025)

• Industry / Commercial: USD$1780    
• Acad / Govt / Non-Profit: USD$980    
• Student / Post-Doc / Fellow: USD$480   
• Accompanying Individual: USD$455

über-Late (after Sep 07, 2025)

• Industry / Commercial: USD$1880    
• Acad / Govt / Non-Profit: USD$1040  
• Student / Post-Doc / Fellow: USD$510   
• Accompanying Individual: USD$480

Last Day Pass (Thu/Fri)

The LAST day pass (Thu/Fri only) is offered at Industry USD$940, Academic USD$520, Student USD$255. This registration type does NOT allow a short course add-on registration. It does NOT allow abstract presentation. It does allow participation in the Fri morning Sunrise Challenge Walk-Run.

What's Included

Access to:

• Exhibit Hall access
• All Program sessions listed in the Conference program, except Short Courses (extra fee)
• All meals as listed in the Conference program.

Payment Method Service Fees added on by MSACL

Credit Card: $0

*Check: $40

*Bank/Wire Transfer: $70

*If you are paying by check or wire transfer, payment must be received by August 29 or the associated registration may be cancelled.

Abstract Submissions

SUBMIT ABSTRACT

Abstract Topics

MSACL is soliciting abstracts for both oral and poster presentations under the topics of:

• Artificial Intelligence
• Assays Leveraging Technology
• Breath Analysis and VOC
• Cases in Clinical Analysis
• Cases of Unmet Clinical Needs
• Data Analytics
• Emerging Technologies
• Environmental Sustainability
• Glycomics
• Identifying High Value Tests
• Informatics
• Lipidomics
• Metabolomics
• Microbiology
• Multi-omics
• Pre-Analytics
• Precision Medicine
• Proteomics
• Spatialomics
• Spatialomics : Automation and AI
• Spatialomics : Pathology and Biomarkers
• Spatialomics : Procedure and Validation
• Spatialomics : Single Cell
• Tox / TDM / Endocrine
• Various OTHER

Presenter Info

General Info

• MSACL Logo Images for placing on your poster (LINK).
• Unless otherwise specified, ALL presenters, including podium presenters, are responsible for covering their costs to attend and present at the conference.
• Conference Registration is Online.
• If you have any questions regarding this information, please contact Chris Herold at [email protected].

Podium Presenter Info

• The deadline to make abstract modifications via your Network Profile is July 23, 2025.
• Abstract presentations are 17 minutes in duration with 3 minutes for questions. You are expected to adhere to this time limit and presentations that go beyond the allotted time will be ended by the moderators.
• Presenter registrations are not comped. All presenters are required to pay the registration fee (or otherwise obtain registration) for the conference.
• Presentations must be created with Microsoft PowerPoint.
• Please download and review at least one of the MSACL 2025 Montreal PPT Slide Templates from the website:
  • Black Bkgd with MSACL Watermark.
  • Black Bkgd, no WM.
  • White Bkgd, no WM.
• Please be aware that only electronic projection in 16:9 format will be available for platform presentations.
• As part of CME requirements, presenters are required to SUBMIT PPT slide decks by DROPBOX for pre-liminary review by August 20. The FINAL version must be uploaded by September 10. This is the version that will be placed on the presentation computer.

SCREEN and PROJECTOR ASPECT RATIO: 16:9

1. Remember to download and review the MSACL 2025 Montreal PPT Slide Template.
2. You MUST submit a preliminary copy of your presentation by August 20 for CME review. Final slide decks must be uploaded by September 10.
3. Please number your slides in the lower right corner. This will help people asking questions to easily reference the slide of interest, and you in finding the slide they are referencing.
4. Podium presentations may NOT include logos from ANY ineligible companies as we are operating under CME Accreditation rules for this conference.
5. Meeting registration is not complimentary.
6. All speakers must self-register online. See Conference Registration. PLEASE COMPLETE YOUR REGISTRATION BEFORE the EarlyBird Registration Deadline of June 18, 2025 or your abstract may be removed from the program.
7. Session Chairs: If an individual is unable to present or does not show, the presentation time slot will be left open. It will NOT be filled by the next speaker. The next speaker will begin presenting at his/her scheduled time.
8. Speakers: Please make an effort to repeat any questions from the audience back to the audience before answering in case other audience members were unable to hear the question asked.
9. Podium presentations are 17 minutes with 3 minutes for Q&A. Total Time is 20 minutes.
10. Laptops running Windows 10 and Office 365 will be provided. PowerPoint and Adobe Reader will be available on all presentation computers.
11. Presenters should check-in 15 minutes prior to the start of their SESSION (not their talk) with either the Session Chair or AV Support on-hand to confirm their talk has been properly placed on the primary presentation computer. ** Make sure to bring a thumb drive as backup!
12. If you are running on a Mac please verify that your presentation will function on a PC running Windows with Office 365.
13. Green laser pointers will be provided.

Poster Presenter Info

• Poster dimensions (for each presenter) are 42 x 42 inches at MAXIMIUM.
• Posters will be attended for 1.25 hours on either Wednesday or Thursday, but your poster should remain posted from Tue-Thu.
  • Posters should be PLACED on Tuesday between 1100-1600.
  • Posters should be REMOVED on Thursday between 1400-1600.
    You will select, or be assigned, a day/time for 1.25 hours on which to ATTEND your poster.
• Poster Boards will be SHARED by two presenters
  • Available poster space (for each presenter) is 42 x 42 inches.
  • Poster Pins WILL BE provided.
  • Poster Boards are Fabric.
• Conference Registration is REQUIRED.
  • If you have not registered by July 23 your poster may be removed from the program.

Sharing Your Poster

You may upload your poster (after it has been accepted and you have confirmed to present) as a PDF file via Manage Abstract. Once your poster is uploaded, a link to download the poster will appear next you your abstract in the online program.

Scientific Program

VIEW THE FULL PROGRAM

Target Audience

The target audience for this program includes pathologists, clinical laboratory directors and scientists, mass spectrometry and automated sample processing providers as well as laboratory diagnostic providers. This program will be beneficial to healthcare administrators, laboratory quality control and standards scientists, as well as those responsible for implementation of clinical analyses for emergency response due to terrorism or accident.

Needs Assessment

With the advancement of technologies for clinical analysis, there exists a gap between those who understand the technology and those who do not. Without continual education, this gap will grow and these advancements are unlikely to be effectively incorporated into the clinical analysis workflow, resulting in lost opportunities to improve patient outcomes and reduce healthcare costs.

MSACL provides an environment through which participants will be able to identify opportunities to develop the capacity to provide higher quality results, more rapidly and for lower overall cost, for patients within the healthcare system.

Invited Speakers

Michael S Bereman Award Lecture

Top-Down High-Resolution Mass Spectrometry for Clinical Testing of Protein Diagnostic Markers

• Ruben Y. Luo (Stanford University)
• Tue September 23 @ 16:45 (04:45 PM) in Montreal 4-5

Today, a large number of protein biomarkers are being quantified for clinical diagnostics, however, the structural characteristics of protein biomarkers are typically not acquired. The lack of such information can result in insufficient analytical specificity or ambiguity. Ambiguity is mainly due to the heterogeneity of proteoforms of a protein biomarker, caused by amino acid variation and post-translational modifications (PTMs). As proteoforms are influenced by pathophysiological conditions, the identification of proteoforms not only clarifies test results, but also provides additional clinical diagnostic value. For instance, the amino acid-mutated proteoforms of hemoglobin are biomarkers of hemoglobinopathies, and β2-transferrin, a specific glycoform of transferrin, has been used as a biomarker for cerebrospinal fluid leaks.

Top-down mass spectrometry (MS) is a novel methodology that analyzes intact proteins without prior enzymatic digestion, allowing for the characterization of proteoforms. It is an ideal tool to identify and study the structural features of diagnostic protein biomarkers. Thus, top-down MS can bring a new dimension of proteoforms to the clinical testing results of protein markers.

In this presentation, the current and prospective applications of top-down MS in clinical laboratories will be discussed. A few cases of successfully developed top-down MS tests will be illustrated in detail, and the unique advantages of top-down MS will be explicated in comparison to conventional immunoassays. In addition, relevant techniques related to the top-down MS methodology, such as sample preparation approaches, liquid chromatography, and capillary electrophoresis, will also be presented.
Distinguished Contribution Award Lecture

Distinguished Contribution Award Lecture

The Crucial Role of Metrology and Precision Diagnostics in Enhancing Patient Management and Clinical Outcomes in Every Patient

• Christa Cobbaert (Leiden University Medical Centre (LUMC))
• Tue September 23 @ 17:40 (05:40 PM) in Montreal 4-5

Molecular characterization of biomarkers in health and disease is a prerequisite for Precision Medicine and holds great potential for personalized patient management and improved outcomes. However, progress in translating molecular biomarkers into medical tests that provide clinical value has been slow. Several barriers contribute to this delay:

Scientific Innovation and Technology Advancement: the current reward system favors the quantity and impact of scientific publications over their effect on patient care.

Identification of Clinical Gaps: identifying gaps in existing clinical care pathways, which are necessary to drive molecular biomarker development, is a cumbersome and costly process under current regulations.
Need for Multiplex Panels: evaluations of biomarker accuracy in diagnostic studies and randomized controlled trials have shown that effective patient classification and personalized management require multiplex panels of molecular markers rather than relying on single markers to detect and monitor complex diseases.

Segregated diagnostic specialties should further increase the value of their examinations by taking a holistic approach to their selection, interpretation, and application to the patient’s care pathway. Integrative Diagnostics should become the norm and its implementation in clinical practice should be realized.
Slow adoption of Artificial Intelligence (AI) as a transformative tool that can guide laboratorians, clinicians and drug developers away from the current simplistic, fragmented and linear thinking about biomarkers and therapy selection.

Advancements in human (patho-)biology and metrology -i.e. the science of measurement- are paving the way for reducing diagnostic uncertainty. Precision Diagnostics, the foundation of Precision Medicine, necessitates a shift towards selective testing that enhances our understanding of interindividual and gender diversity, as well as (patho-)biology at the molecular level. This approach can potentially alleviate some of the current inadequacies in clinical care pathways due to suboptimal tests, which lead to misclassifications and avoidable patient harm.

Molecular tests also offer the advantage of being standardizable to the SI system, as outlined in the Meter Convention at BIPM, Paris, France. This allows for the proper implementation of metrological traceability from the outset. Over the last decade, mass spectrometry (MS) has gained momentum in laboratory medicine, proving its potential as a truly selective measurement platform, particularly for replacing flawed immunoassays. This is especially true for small molecules, such as steroids and immunosuppressive drugs in transplant patients, as well as for blood-based protein tests featuring clinically relevant proteoforms. Automated MS-based platforms are currently available for use in accredited medical laboratories and include a growing menu of CE-IVD and/or FDA-approved tests.

The parallel evolution of Metrology, Science, and Technology is crucial for enabling the paradigm shift from curative care to preventive, predictive, personalized medicine with patient participation (P4-Medicine). It is essential to develop more personalized, safe, and effective medical tests that improve the benefit/harm ratio for every patient and meet the predefined clinical performance goals set forth in clinical guidelines. Representative proof-of-principle use cases will be presented that support this consequentialist approach.

In conclusion, the (r)evolution towards Precision Medicine and Integrative Diagnostics, as a foundation for P4-Medicine and for affordable, sustainable healthcare, aligns with recent presidential recommendations from clinical and laboratory professional societies. These developments call for your involvement and proactiveness as future medical lab leaders to exploit all “enablers” for improving clinical outcomes and patient safety in every patient!

Plenary Lectures

AI Deployment in the Clinical Laboratory: Practical Considerations and Lessons Learned

• David McClintock (Mayo Clinic)

Deciphering Proteopathies: Molecular Fingerprinting of Neurodegenerative Diseases

• Judith Steen (Harvard Medical School & Boston Children's Hospital)
• Wed September 24 @ 09:00 (09:00 AM) in Montreal 4-5

Neurodegenerative disorders such as Alzheimer’s Disease, Frontotemporal Degeneration, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis share a common pathological signature: the aggregation of specific proteins, including tau, TDP43, and alpha-synuclein. These proteopathies represent a critical juncture where normal proteins transform into pathological entities, driving neuronal dysfunction and death. Despite decades of research, the precise molecular mechanisms governing this transformation remain elusive.

To address this fundamental gap, we developed innovative mass spectrometry-based proteomic platforms with unprecedented sensitivity and specificity for characterizing disease-associated protein modifications. Our approaches comprehensively map and quantify post-translational modifications on pathological protein aggregates extracted from human patients and animal models across disease progression timelines. By analyzing these "molecular fingerprints" in large patient cohorts, we have revealed distinct modification patterns that define disease stages, patient subtypes, and predict clinical trajectories.

Our studies have uncovered the sequential accumulation of tau modifications during Alzheimer’s pathogenesis and identified specific chemical alterations that enhance tau’s propensity to aggregate and propagate between neurons. Importantly, these precise molecular characterizations distinguish pathological protein species from their normal counterparts, enabling the development of highly selective therapeutic strategies that target disease-driving protein forms while preserving essential physiological functions.

This presentation will highlight how quantitative proteomics has transformed our understanding of proteopathies and demonstrate how these insights create new paradigms for early diagnosis and precision therapeutics in neurodegenerative diseases.

Short Courses

All times are EASTERN TIME.

September 7 is the FINAL DEADLINE to register for Pre-Con Short Courses !

• The Short Courses for MSACL 2025 will be held only In-Person.
• Short courses will be from 8-16 hrs.
• You MUST be registered for the conference in order to attend a Short Course. Short Courses have an additional fee.

Click Here to Start Your Conference and Short Course Registration

Short Course Pricing (per HOUR):

EarlyBird by June 18, 2025

• Industry: $45/h
• Academic: $35/h
• Student: $13/h

Regular after June 18, 2025

• Industry: $50/h
• Academic: $38/h
• Student: $16/h

Late after July 23, 2025

• Industry: $60/h
• Academic: $41/h
• Student: $20/h

űber-Late after September 07, 2025

• Industry: CLOSED
• Academic: CLOSED
• Student: CLOSED

Course Offering

• Automation 201 : Streamlining Clinical Analysis through Efficient Workflow Integration
  • September 22 Monday 08:30 - September 23 Tuesday 12:30 (12 hours)
• Clinical Proteomics 201 : Clinical Proteomics
  • September 22 Monday 08:30 - September 23 Tuesday 12:30 (12 hours)
• Clinical Proteomics 202 : MS-based Precision Diagnostics by Molecular Protein Analysis
  • September 21 Sunday 14:30 - September 22 Monday 12:30 (8 hours)
• Data Science 100 : Data Literacy
  • September 22 Monday 14:30 - September 23 Tuesday 12:30 (8 hours)
• Data Science 101 : Breaking Up with Excel : An Introduction to the R Statistical Programming Language
  • September 21 Sunday 14:30 - September 23 Tuesday 12:30 (16 hours)
• Data Science 203 : Machine Learning : A Gentle Introduction
  • September 21 Sunday 14:30 - September 23 Tuesday 12:30 (16 hours)
• Glyco(proteo)mics 101 : Clinical Glyco(proteo)mics by Mass Spectrometry
  • September 22 Monday 08:30 - September 23 Tuesday 12:30 (12 hours)
• Isotopes 101 : Modern Isotope Ratio Analysis for Biomedical Research and Clinical Diagnostics
  • September 22 Monday 14:30 - September 23 Tuesday 12:30 (8 hours)
• LC-MSMS 101 : Getting Started with Quantitative LC-MSMS in the Diagnostic Laboratory
  • September 21 Sunday 14:30 - September 23 Tuesday 12:30 (16 hours)
• LC-MSMS 203 : Validation of Quantitative LC-MS/MS Assays for Clinical and Academic Use
  • September 22 Monday 08:30 - September 23 Tuesday 12:30 (12 hours)
• LC-MSMS 302 : Advanced LC-MSMS Method Development, Troubleshooting and Operation for Clinical Analysis
  • September 21 Sunday 14:30 - September 23 Tuesday 12:30 (16 hours)
• Lipidomics 101 : Mass Spectrometry-based Lipidomics and Clinical Applications
  • September 22 Monday 14:30 - September 23 Tuesday 12:30 (8 hours)

Trainee Poster Contest

• ELIGIBILITY: To be eligible you must be a current TRAINEE (e.g., students, post-docs, residents, fellows or similar), or your training program must have ended after September 1, 2024. Reasonable exceptions may apply. Troubleshooting posters are not eligible.
• LOGISTICS: Participants must indicate interest via Abstract Management through their Network Directory Profiles (if not already indicated during abstract submission) and upload a PDF of their poster by September 1.
• POSTER UPLOAD: Participants will need to upload a PDF of their poster via their Network Directory Profile by September 1, so that it may be reviewed by the judges to select the Finalists who will be interviewed by the Poster judges during their poster presentation period.
• ROUND ONE: Review of PDF Posters: The Judging Committee will review the Candidate Posters via the Uploaded PDFs (deadline September 1). Each judge will select their 4 top posters, in order of preference. From these selections the Judging Committee will identify the finalists (~6-8). Finalists will be notified by email by September 11 and move to Round two.
• ROUND TWO: Oral Presentation & Defense: [during each finalist's poster attendance period]. Each judge will spend 3-5 minutes at each finalist's poster to collect information by which to determine the poster award winners . The judges may perform the finalist interviews as a group, in smaller groups, or individually, with each judge selecting their top 4 posters from which the winners will be determined. There will be up to 3 winners of up to $500 each, depending on number of participants and quality of the posters.
• AWARDS: Awardees will be announced on Thursday September 25 at 17:30 prior to the Pub-Style Trivia Dinner. Up to three winners will receive awards of 500 USD, payable via PayPal.

Vendor Exhibits

Exhibit Schedule Overview

Tuesday September 23, 2025

• 08:00 - 16:00 Set-Up
• 18:30 - 21:30 SHOW

Wednesday September 24, 2025

• 11:30 - 17:45 Flow Schedule

Thursday September 25, 2025

• 08:30 - 13:30 Flow Schedule
• 14:00 - 18:30 Breakdown

Exhibit Hall Schematic

The MSACL 2025 Exhibit Hall will be in the Hotel Bonaventure Conference Center. There will also be posters and food served in the Exhibit Hall. The Exhibit Booths will be 8 x 10 feet.

MSACL 2025: Hotel Bonaventure Conference Center - Exhibit Hall Diagram

Registered Exhibitors

Company / Booth #

• A Chemtek / 26
• AFFINISEP / 25
• Agilent Technologies / 27, 28 (2 booths)
• ASI Chemicals / 15
• Biotage  / 7
• Bruker Scientific  / 24
• Cambridge Isotope Labs / 18
• Chromsystems / 16
• DPX Technologies  / TBD
• Endotherm / 8
• Evosep Biosystems / 12
• Hamilton Company / 22
• Immundiagnostik  / 9
• Indigo BioAutomation  / 3,4 (2 booths)
• IonOpticks / 21
• Kura Biotech (summary) / 5
• Phenomenex / 31
• Phytronix Technologies / 16
• PreOmics / 6
• Restek / 32
• Roche / 47 (4 booths)
• SCIEX / 29/30/31 (3 booths)
• Tecan / 43, 44 (2 booths)
• Thermo Fisher Scientific / 1, 2 (2 booths)
• Waters Corporation / 13/14 (2 booths)
• Zef Scientific / 17

Industry Workshops

Early Bird Deadline: March 18, 2025.

The Industry Workshop Application is in the Vendor Prospectus that can be downloaded by clicking the link below:

Download Vendor Prospectus

Workshop Assignments

Any workshop slot that appears taken may be preferentially selected, based on sponsorship level, up through the end of the Early Bird date.

Tuesday September 23, 2025

• 12:45 - 14:00 Montreal 4: Roche
• 12:45 - 14:00 Montreal 5: Shimadzu
• 12:45 - 14:00 Montreal 6-8: Thermo Fisher Scientific

Wednesday September 24, 2025

• 07:30 - 08:25 Montreal 4: Waters Corporation
• 07:30 - 08:25 Montreal 5: Agilent Technologies
• 07:30 - 08:25 Montreal 6-8: Phenomenex

Workshop Logistics

Industry Workshops provide an opportunity for MSACL conference attendees to learn more about specific applications or products of interest as presented by sponsoring vendors.

• The listed fee includes projector, screen and microphone.
• These workshops are offered at no charge to attendees.
• Any Workshop pre-registration to be managed by Vendor Host.

Title must be uploaded online by July 31, 2025 to make the conference digest program. 

Workshop Promotion

As a Workshop Sponsor, to promote your event you may use the email list of attendees that have opted-in for exhibitor contact provided as part of your booth package. If you do not have a booth package, you will receive a copy of the opt-in registrants within 7 days after the regular registration deadline.

On the day of your event you will be provided a table, chair in front your booked rooms. You will also be permitted to place one piece of signage in front of the room up to 30 minutes prior to the event.

Industry Workshop Summaries

Tuesday September 23

• 12:45 - 14:00 in Montreal 4 with Roche
• Workshop summary coming soon ...
• 12:45 - 14:00 in Montreal 5 with Shimadzu
• Workshop summary coming soon ...
• 12:45 - 14:00 in Montreal 6-8 with Thermo Fisher Scientific
• Workshop summary coming soon ...

Wednesday September 24

• 7:30 - 8:25 in Montreal 4 with Waters Corporation
• Workshop summary coming soon ...
• 7:30 - 8:25 in Montreal 5 with Indigo BioAutomation
• Workshop summary coming soon ...
• 7:30 - 8:25 in Montreal 6-8 with Agilent Technologies
• Workshop summary coming soon ...

Educational Grants

MSACL invests heavily in education via the MSACL Educational Grants, which support conference attendance:

• Young Investigator Grants: Young investigators, in the first four years of their academic position, who submit an abstract which is accepted for presentation (poster/podium) at the annual conference. Applicants must submit a short application.
• Lab Director Grants: Lab Directors interested in learning more about what mass spectrometry is and how it could potentially improve results and reduce costs in their clinical laboratory are not required to submit an abstract, but must submit a short application.
• Trainee Grants: Lab Directors-to-be interested in learning more about what mass spectrometry is and how it could potentially improve results and reduce costs in their clinical laboratory are not required to submit an abstract, but must submit a short application.

Venues

Location Overview

The Bonaventure Hotel is located in the heart of downtown Montréal on the 10th floor of Place Bonaventure building. The hotel has 397 guest rooms, their own internal meeting space (just a short escalator ride down from the hotel lobby), two restaurants and a bar. The hotel also features lush gardens, a rooftop outdoor heated pool (open year round), and offers panoramic views of the city, making it a distinctive and iconic location in Montréal.

We will be using the Bonaventure's St-Laurent room as the MSACL Exhibit Hall (20,140 square feet). There will be space for at 40+ booths interspersed with up to 162 posters.

The Scientific Sessions will be held in the Salle de Balle de Montréal (Montréal Ballroom).

There were 562 attendees for MSACL 2024. We are expecting about 600-700 for MSACL 2025 with a greater representation from the East Coast and Europe given this is the first time the conference will be held outside of California.

Hotel Bonaventure

900 Rue De la Gauchetière O, Montréal, QC H5A 1E4, Canada
Tel: +1 514-878-2332

Venue plan: Hotel Bonaventure

MSACL 2025: Hotel Bonaventure Conference Center Venue Diagram